About

Amirali Salmasi is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes for prostate and upper tract urothelial cancers, with a particular focus on robotic-assisted techniques. His major contributions include demonstrating that surgical approach significantly impacts lymph node dissection yield and survival in upper tract urothelial carcinoma (64 citations), and establishing that PI-RADS version 2 scoring on multiparametric prostate MRI predicts oncologic outcomes in Gleason 3+4 prostate cancer (27 citations). Salmasi has also advanced understanding of functional recovery after robot-assisted radical prostatectomy, providing comprehensive analysis of sexual function outcomes (24 citations) and establishing the safety of higher pneumoperitoneum pressures during the procedure (17 citations). His work on regional cost variations of robotic versus open prostatectomy (30 citations) has informed healthcare economics discussions. More recently, he has investigated multimodal analgesia protocols to improve recovery after robotic nephrectomy. With over 195 citations across his most influential papers, Salmasi's research bridges surgical technique, oncologic outcomes, and patient quality of life, making him a notable contributor to the evidence base for minimally invasive urologic oncology.

Research Focus

Key Achievements

7
H-Index
9
Papers
195
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma
64 citations · 2017
📈 Most Prolific Year: 2015 (3 Papers)
🤝 Key Collaborators: 56
🏛 Institutions: University of California, Los Angeles, Rutgers, The State University of New Jersey, Rutgers Cancer Institute of New Jersey, University of California San Diego

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago